GlassScriptPhysician profile
Safwan Kassas
NPI 1467432500
$340,018.91
in general payments reported to CMS, 2019-2025
23 companies · $29K in 2025
The $29K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $41K · 2021: $58K · 2022: $42K · 2023: $55K · 2024: $26K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $75K · Travel and Lodging: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,250 · Food and Beverage: $3,585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $75,150.00 |
| Travel and Lodging | $24,021.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,250.00 |
| Food and Beverage | $3,584.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $337,277.66 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Abbott Laboratories | $1,003.45 | 2021-2025 | Mitraclip, Optis |
| Biocardia, INC. | $291.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $285.98 | 2019-2024 | |
| Boston Scientific Corporation | $235.96 | 2019-2025 | Watchman Flx |
| Medtronic, INC. | $134.97 | 2022-2023 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.94 | 2019-2025 | Lifevest |
| Cardiac Dimensions, INC. | $116.50 | 2022-2023 | |
| W. L. Gore & Associates, INC. | $113.01 | 2020 | |
| Medtronic Vascular, INC. | $79.80 | 2020 | |
| Recor Medical INC | $46.59 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Amgen INC. | $43.49 | 2019-2024 | Repatha |
| Cardiva Medical, INC. | $35.14 | 2019-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| E.R. Squibb & Sons, L.L.C. | $30.21 | 2019-2023 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.24 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $26.32 | 2023 | Zio Xt Patch |
| Shockwave Medical, INC | $24.84 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $24.07 | 2025 | |
| Pfizer INC. | $23.63 | 2019 | |
| Teleflex LLC | $18.50 | 2021 | |
| Biosense Webster, INC. | $17.53 | 2020 | |
| Biotronik INC. | $15.26 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Safwan Kassas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.